Astrazeneca (AZN) Debt Ratio (2009 - 2026)

Astrazeneca's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.21 for Q1 2026.

• In Q1 2026, Debt Ratio rose 14.62% year-over-year to 0.21; the TTM figure through Mar 2026 stood at 0.21 (up 14.62% YoY), while the FY2025 annual figure was 0.19, down 168.33% from the prior year.
• Debt Ratio was 0.21 for Q1 2026 at Astrazeneca, down from 0.19 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 87.84 in Q4 2023 to a low of 0.28 in Q1 2022.
• Historically, Debt Ratio has averaged 5.0 across 5 years, with a median of 0.24 in 2022.
• The sharpest annual moves came in 2023 and 2025: Debt Ratio soared 29869.56% in 2023, then plunged 168.33% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.29 in 2022, then jumped by 29869.56% to 87.84 in 2023, then sank by 99.68% to 0.28 in 2024, then slumped by 168.33% to 0.19 in 2025, then decreased by 13.21% to 0.21 in 2026.
• The last three Debt Ratio figures came in at 0.21 (Q1 2026), 0.19 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.